25.2.05 - I nuovi farmaci per l’obesità, luci e ombre

from Med Magazine · host Regia Congressi Editore

I nuovi farmaci per l'obesità, basati sulle incretine, mostrano una significativa perdita di peso e benefici cardiovascolari, ma d'altra parte presentano effetti collaterali gastrointestinali, alti costi e una durata d'uso limitata. Nella nuova puntata viene analizzato il bilancio tra i "pro" e i "contro": da che parte pende la bilancia?

Episode metadata supplied by the publisher feed · Published Jun 1, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

25.2.05 - I nuovi farmaci per l’obesità, luci e ombre

0:00 9:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Med Magazine?

This episode is 9 minutes long.

When was this Med Magazine episode published?

This episode was published on June 1, 2025.

Can I download this Med Magazine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!